Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease

Area of Science:

• Oncology
• Hepatobiliary Surgery

Background:

• Colorectal cancer is a leading cause of cancer-related mortality in the USA.
• Metastatic disease develops in up to 50% of patients, with the liver as the most frequent site.
• Borderline-resectable colorectal liver metastases represent a challenging clinical entity.

Purpose of the Study:

• To define and discuss borderline-resectable colorectal liver metastases.
• To outline current workup and staging protocols for this condition.
• To review management strategies aimed at improving resectability.

Main Methods:

• Literature review focusing on borderline-resectable colorectal liver metastases.
• Analysis of diagnostic workup and staging methodologies.
• Synthesis of current surgical and medical treatment approaches.

Main Results:

• The definition and clinical significance of borderline-resectable colorectal liver metastases are clarified.
• Standardized workup and staging are crucial for appropriate management.
• Multidisciplinary management strategies can enhance resectability rates.

Conclusions:

• Accurate diagnosis and staging are essential for managing borderline-resectable colorectal liver metastases.
• A combination of surgical techniques and medical therapies can improve patient outcomes.
• Further research is needed to optimize treatment protocols for this patient group.